Takeda Pharmaceutical
283 hedge funds and large institutions have $1.15B invested in Takeda Pharmaceutical in 2024 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 90 increasing their positions, 102 reducing their positions, and 55 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
10% less funds holding
Funds holding: 313 → 283 (-30)
12% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 102
47% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 55
Holders
283
Holding in Top 10
2
Calls
$23.6M
Puts
$3.06M
Top Buyers
| 1 | +$89.8M | |
| 2 | +$26.2M | |
| 3 | +$12.3M | |
| 4 |
CAC
Cowen and Company
New York
|
+$6.87M |
| 5 |
VanEck Associates
New York
|
+$4.61M |
Top Sellers
| 1 | -$60.8M | |
| 2 | -$15.5M | |
| 3 | -$7.98M | |
| 4 |
BlackRock
New York
|
-$7.22M |
| 5 |
Goldman Sachs
New York
|
-$6.37M |